Bartsch, Rupert
Rinnerthaler, Gabriel
Petru, Edgar
Egle, Daniel
Gnant, Michael
Balic, Marija
Sliwa, Thamer
Singer, Christian
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 10 July 2023
Accepted: 17 July 2023
First Online: 8 September 2023
Conflict of interest
: R. Bartsch: advisory role: Astra-Zeneca, Daiichi, Eisai, Eli-Lilly, Gilead, MSD, Novartis, Pfizer, Pierre-Fabre, Puma, Roche, Seagen; lecture honoraria: Astra-Zeneca, Daiichi, Eli-Lilly, Gilead, Novartis, Pfizer, Pierre-Fabre, Roche, Seagen; research support: Daiichi, MSD, Novartis, Roche. G. Rinnerthaler: consulting or advisory role: Piere Fabre, Celgene, Roche, Novartis, Pfizer, Eli Lilly, Daiichi Sankyo, MSD; speakers’ bureau: Amgen, Astra-Zeneca, Novartis, Bristol-Myers Squibb, Roche, Pfizer, Eli Lilly; research funding: Roche; travel, accommodation, expenses: Roche, Novartis, Amgen, Pfizer, Bristol-Myers Squibb. E. Petru: honoraria for lectures: AGEA, Amgen, Astra-Zeneca, Angelini, Eisai, Eli Lilly, GlaxoSmithKline, MSD, Novartis, Pharma Mar, Pfizer, Roche; honoraria for advisory boards: Amgen, Astra-Zeneca, Angelini, Eisai, Eli Lilly, GlaxoSmithKline, MSD, Novartis, Pharma Mar, Pfizer, Roche, Clovis, Daiichi Sankyo; honoraria (institution): Amgen, Astra-Zeneca, Angelini, Eli Lilly, GlaxoSmithKline, Novartis, Pharma Mar, Pfizer, Roche, TESARO; travel expenses: AGEA, Amgen, Astra-Zeneca, GlaxoSmithKline, Pharma Mar, Pfizer, Roche. D. Egle: honoraria and travel grants: Astra-Zeneca, Amgen, Daiichi-Sankyo, Eli Lilly, MSD, Novartis, Pfizer, Roche, Seagen. M. Gnant: personal fees/travel support: Daiichi Sankyo, AstraZeneca, EliLilly, LifeBrain, Nanostring, Novartis, PierreFabre, MSD; other: an immediate family member is employed by Sandoz. M. Balic: research funding: Astra-Zeneca, Eli Lilly, Novartis, Pfizer, Samsung; advisory role: Amgen, Astra-Zeneca, Celgene, Daiichi Sankyo, Eli Lilly, MSD, Novartis, Pierre Fabre, Pfizer, Roche, Samsung; speaker’s bureau: Amgen, Astra-Zeneca, Celgene, Daiichi Sankyo, Eli Lilly, Gilead, Novartis, Pierre Fabre, Pfizer, Roche, Seagen. T. Sliwa: honoraria and advisory boards: Roche, Daiichi Sankyo, Eli Lilly. C. Singer: advisory role: Astra-Zeneca, Daiichi, Eli-Lilly, Novartis, Pfizer, Roche; lecture honoraria: Astra-Zeneca, Roche, Amgen, Eli-Lilly, Novartis, Pfizer; research support: Daiichi, Amgen, Novartis, Roche.